NewGenIvf Group Ltd is a SG-based company operating in Health Care Providers & Services industry. The company employs 76 full-time employees The company went IPO on 2022-02-15. NewGenIvf Group Limited is a comprehensive fertility services provider in Asia, helping couples and individuals obtain access to fertility treatments. The firm offers services, such as Mitochondrial Replacement Therapy (MRT) In Reproductive, Intrauterine Insemination (IUI), MRT techniques, In Vitro Fertilization (IVF) and Intracytoplasmic Sperm Injection (ICSI), semen analysis, testicular/epididymal sperm aspiration or extraction/percutaneous epididymal sperm aspiration, embryo transfer, chromosome screening, and egg freezing. The Company’s clinics are located in Thailand, Cambodia, and Kyrgyzstan, and present a full suite of services for its patients, including comprehensive infertility and assisted reproductive technology treatments, egg and sperm donation, and surrogacy, in the appropriate jurisdictions. The Company’s subsidiary is NewGenIvf Limited.
Follow-Up Questions
NewGenIvf Group Ltd (NIVF) 的市盈率是多少？
NewGenIvf Group Ltd 的市盈率是 N/A
NewGenIvf Group Ltd 的 CEO 是谁？
Mr. Claudius Tsang 是 NewGenIvf Group Ltd 的 Chairman of the Board，自 2021 加入公司。
NIVF 股票的价格表现如何？
NIVF 的当前价格为 1.87，在上个交易日 increased 了 0.29%。
NewGenIvf Group Ltd 的主要业务主题或行业是什么？
NewGenIvf Group Ltd 属于 Health Care 行业，该板块是 Health Care
